# US 2010/0303877 A1 · Controlled Release Hydrogel Films

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0303877 A1
- Document ID: US20100303877A1
- Status: Published application
- Kind: A1
- Application number: 12/791,845
- Filed: 2010-06-01
- Published: 2010-12-02
- Earliest claimed: 2009-06-01
- Assignees: Board of Regents, The University of Texas System
- Inventors: Richard B. Timmons; Wen Chyan; Dhiman Bhattacharyya
- Web page: https://patentgrep.com/patent/US20100303877A1

## CPC

- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A01N 25/04: Dispersions, {emulsions, suspoemulsions, suspension concentrates} or gels (foams A01N25/16)
- A01N 59/16: Heavy metals; Compounds thereof
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 33/38: Silver; Compounds thereof
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides hydrogels and methods of making hydrogels with precisely controlled levels of chemical compositions by mixing one or more monomers in a plasma reactor; polymerizing the one or more monomers into a polymer; crosslinking the polymer to form a hydrogel; immersing the hydrogel in a first solution; and adsorbing one or more solute species from the solution, wherein the one or more solute species are released at controlled rates.

## Claims

### Claim 1

A process to synthesize hydrogels with precisely controlled levels of chemical compositions comprising the steps of:
mixing one or more monomers in a plasma reactor;
polymerizing the one or more monomers into a polymer;
crosslinking the polymer to form a hydrogel;
immersing the hydrogel in a first solution; and
adsorbing one or more solute species from the solution, wherein the one or more solute species are released at controlled rates.

### Claim 2 (depends on 1)

The process of claim 1, further comprising the step of immersing the hydrogel in a second solution and adsorbing one or more capping agents from the second solution, wherein the one or more capping agents modify the release rate of the one or more solute species.

### Claim 3 (depends on 1)

The process of claim 1, further comprising the step of adjusting a variable duty cycle pulsed plasma, a continuous wave plasma, or both to polymerize the one or more monomers into the polymer to control a polymer cross-link density and a thickness.

### Claim 4 (depends on 1)

The process of claim 1, wherein the one or more solute species comprise one or more bioactive agents, active agents, drugs or antimicrobial agents.

### Claim 5 (depends on 1)

The process of claim 1, wherein the one or more solute species comprise one or more silver ions that are spontaneously reduced to one or more elemental silver particles after adsorption by the hydrogel.

### Claim 6 (depends on 5)

The process of claim 5, wherein the one or more elemental silver particles are nanosized particles, having diameters of 1-75 nm.

### Claim 7 (depends on 1)

The process of claim 1, further comprising the steps of varying the one or more monomers, a plasma deposition variable or both to control a behavior at a lower critical solution temperature.

### Claim 8 (depends on 7)

The process of claim 7, wherein the lower critical solution temperature can be controllably varied over the temperature range of approximately 30° C. to 60° C.

### Claim 9 (depends on 1)

The process of claim 1, wherein the one or more capping agents has a surface energy ranging from highly non-wettable (hydrophobic) to highly wettable (hydrophilic).

### Claim 10 (depends on 1)

The process of claim 1, wherein the one or more capping agents modify the release rate of the one or more solute species to eliminates an initial surge release of the one or more solute species.

### Claim 11 (depends on 1)

A hydrogel made by the process of claim 1.

### Claim 12

A hydrogel with precisely controlled levels of active agents comprising:
a mixture of one or more monomers polymerized in to a polymer in a plasma reactor;
one or more crosslinks connecting the polymer to form a hydrogel; and
one or more solute species associated with the polymer, wherein the one or more solute species are released at controlled rates from the polymer.

### Claim 13 (depends on 12)

The hydrogel of claim 12, further comprising one or more capping agents connected to the one or more solute species, the polymer, or both to modify the release rate of the one or more solute species.

### Claim 14 (depends on 12)

The hydrogel of claim 12, wherein a polymer cross-link density and a thickness are controlled by a duty cycle pulsed plasma, a continuous wave plasma, or both to polymerize the one or more monomers into the polymer.

### Claim 15 (depends on 12)

The hydrogel of claim 12, wherein the one or more solute species comprise one or more bioactive agents, active agents, drugs or antimicrobial agents.

### Claim 16 (depends on 12)

The hydrogel of claim 12, wherein the one or more solute species comprise one or more silver ions, that are spontaneously reduced to one or more elemental silver particles after adsorption by the hydrogel.

### Claim 17 (depends on 16)

The hydrogel of claim 16, wherein the one or more elemental silver particles are nanosized particles, having diameters of 1-75 nm.

### Claim 18 (depends on 1)

The hydrogel of claim 1, wherein the lower critical solution temperature behavior is controlled the one or more monomers, a plasma deposition variable or both.

### Claim 19 (depends on 22)

The hydrogel of claim 22, wherein the lower critical solution temperature is controlled over the temperature range of approximately 30° C. to 60° C.
